Cite
HARVARD Citation
Spahn, J. et al. (n.d.). Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models. Journal for immunotherapy of cancer. p. . [Online].